- Zacks•5 hours ago
Regeneron Pharmaceuticals, Inc. (REGN) is scheduled to release first-quarter 2017 results on May 4, before the opening bell.
- The Wall Street Journal•11 hours ago
French drugmaker Sanofi said 1Q net profit jumped to about $6.2 billion, boosted by the sale of its animal-health business. To revive growth, Sanofi has boosted its research and is seeking to acquire an ...
- American City Business Journals•12 hours ago
Shares of Sarepta Therapeutics soared Friday morning amid speculation that the planned departure of CEO Ed Kaye makes the Cambridge biotech a prime takeover target. Kaye made the surprise announcement on a conference call with analysts Thursday, saying that he will step down from his role as CEO of Sarepta (SRPT) by the end of the year, but will remain on the company’s board. Meanwhile, TheStreet’s Adam Feuerstein speculated Friday that Sanofi (SNY) could emerge as a suitor.
SNY : Summary for Sanofi American Depositary Shar - Yahoo Finance
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||46.90 - 47.52|
|52 Week Range||36.81 - 47.52|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||24.31|
|Dividend & Yield||1.58 (3.40%)|
|1y Target Est||N/A|